Stock comparison
Guardant Health, Inc. is 3.1x more valuable than Caris Life Sciences, Inc. by market capitalization ($21.99 B vs $7.02 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
GH is larger
Guardant Health, Inc. is 3.1x more valuable than Caris Life Sciences, Inc. by market capitalization ($21.99 B vs $7.02 B).
Market value leader
GH
Guardant Health, Inc. is 3.1x more valuable than Caris Life Sciences, Inc. by market capitalization ($21.99 B vs $7.02 B).
Revenue leader
GH
GH: $982.02M vs CAI: $812.03M.
Profit leader
CAI
GH: -$416.30M vs CAI: -$68.09M.
Margin leader
CAI
GH: -42.4% vs CAI: -8.4% net margin.
| Metric | GH | CAI |
|---|---|---|
| Market cap | $21.99 B | $7.02 B |
| US-listed rank | #593 | #1173 |
| Revenue (latest FY) | $982.02M | $812.03M |
| Net income (latest FY) | -$416.30M | -$68.09M |
| Net margin | -42.4% | -8.4% |
| P/E (trailing FY) | - | - |
| SEC filings | 1,131 | 102 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
Guardant Health, Inc. is 3.1x more valuable than Caris Life Sciences, Inc. by market capitalization ($21.99 B vs $7.02 B).
In their latest fiscal years, Guardant Health, Inc. reported $982.02M in revenue while Caris Life Sciences, Inc. reported $812.03M.
Full pages: Guardant Health, Inc. and Caris Life Sciences, Inc., or browse the full rankings.